Detail akcie Tactile Systms T Rg online

Business Summary: Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Tactile Systems Technology Inc revenues increased 11% to $274.4M. Net income totaled $28.5M vs. loss of $17.9M. Revenues reflect Lymphedema products segment increase of 14% to $241.7M. Net Income reflects Intangible asset amortization and earn-o decrease of 99% to $76K (expense), Stock-based Compensation in S& M decrease of 26% to $3M (expense).